DeHeng Advised Jiangsu APON Medical Technology Co., Ltd.
on Listing on ChiNext
2018-12-15
On December 13, 2018, Jiangsu APON Medical Technology Co., Ltd. ("APON Medical", stock code: 300753) was listed on the ChiNext board of the Shenzhen Stock Exchange. A total of 20.2 million shares were issued this time, with an issue price of 15.80 yuan per share. After the IPO, the company’s total share capital reached 80.8 million shares, and the total raised funds were 319.16 million yuan, all of which were raised by public offering of new shares.
APON Medical, established in 2001, focuses on the two major areas of pain management and ophthalmology and otolaryngology. Its main products include "Electronic Injection Pump", "Microcomputer Automatic Injection Pump", "Disposable Infusion Pump", "Postoperative analgesia central monitoring and management system", "Physiological seawater nasal care sprayer", "Hypertonic buffered seawater nasal care sprayer", etc. As an innovative tech company, APON Medical has formed an innovation mechanism integrating industry, academics and research through close cooperation with many experts and scholars from well-known universities and medical institutions in China. With evidence-based medical diagnosis and treatment as the basis for research and development of products and services, the company pursues technological development and innovation, and provides medical solutions and technologies for customers. APON Medical is currently the only manufacturer involved in the development of "portable electric infusion pump" industry standards.
Group photo of DeHeng lawyers and client representatives (first from left attorney Liu Yunzhou, second from left attorney Zhu Qin, third from left APON Medical chairman Mr. Wang Ningyu, second from right partner Gao Hui, first from right assistant attorney Liu Ting)
As the legal counsel of APON Medical's IPO, DeHeng formed a project team headed by Gao Hui, a partner of the Shanghai office, supported, among others, by attorney Zhu Qin, attorney Liu Yunzhou and assistant attorney Liu Ting. The team was fully involved in the structuring of the IPO project, research on major and difficult legal issues, drafting of relevant information disclosure documents, issuance of legal opinions, and participation in communication with regulators. The team provided professional, comprehensive and efficient legal services to help APON Medical enter the capital market. DeHeng has worked hand in hand with the client to witness the development of APON Medical, and has been fully recognized and highly trusted by the client. In the future, DeHeng will continue to provide professional, comprehensive and high-quality legal services for domestic and foreign customers.
